דטסקאן

Nchi: Israeli

Lugha: Kiebrania

Chanzo: Ministry of Health

Viambatanisho vya kazi:

IOFLUPANE

Inapatikana kutoka:

ELDAN ELECTRONIC INSTRUMENTS CO LTD

ATC kanuni:

V09AB03

Dawa fomu:

תמיסה להזרקה

Tungo:

IOFLUPANE 74 MBQ/ML

Njia ya uendeshaji:

תוך-ורידי

Dawa ya aina:

מרשם נדרש

Viwandani na:

GE HEALTHCARE B.V., THE NETHERLAND

Kundi la matibabu:

OTHER DOPAMINERGIC AGENTS

Eneo la matibabu:

IODINE IOFLUPANE (123I)

Matibabu dalili:

Datscan is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum: - of patients with clinically uncertain Parkinsonian Syndromes in order to help differentiate Essential Tremor from Parkinsonian Syndromes related to idiopathic Parkinson's Disease Multiple System Atrophy and Progressive Supranuclear Palsy. - Datscan is unable to discriminate between Parkinson's Disease Multiple System Atrophy and Progressive Supranuclear Palsy. - To help differentiate probable dementia with Lewy bodies from Alzheimer's disease. Datscan is unable to discriminate between dementia with Lewy bodies and Parkinson's disease dementia

Idhini ya tarehe:

2014-11-30